Urologix, Inc. (ULGX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 14, 2025
Urologix Revenue
Urologix had revenue of $2.75M in the quarter ending March 31, 2015, a decrease of -16.71%. This brings the company's revenue in the last twelve months to $12.00M, down -19.41% year-over-year. In the fiscal year ending June 30, 2014, Urologix had annual revenue of $14.01M, down -15.00%.
Revenue (ttm)
12.00M
Revenue Growth
-19.41%
P/S Ratio
0.00
Revenue / Employee
196.70K
Employees
61
Market Cap
2.13K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2014 | 14.01M | -2.47M | -15.00% |
Jun 30, 2013 | 16.48M | -543.00K | -3.19% |
Jun 30, 2012 | 17.03M | 4.46M | 35.45% |
Jun 30, 2011 | 12.57M | -2.20M | -14.89% |
Jun 30, 2010 | 14.77M | 1.96M | 15.25% |
Jun 30, 2009 | Pro | Pro | Pro |
Jun 30, 2008 | Pro | Pro | Pro |
Jun 30, 2007 | Pro | Pro | Pro |
Jun 30, 2006 | Pro | Pro | Pro |
Jun 30, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |